Tissue demand is expected to weaken further from the first quarter shipments of 11 point 7 million cases, as our shipments in April are at 3.1 million cases compared to a monthly average in the first quarter of 2021 a 3.9 million cases to address our elevated inventory levels, and expected lower demand from our customers in the short term.
